abstract |
The present invention relates to novel peptide compounds which are effective in modulating one or more melanocortin receptor types, to the use of the compounds in therapy, to meth- ods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the in- vention are of particular interest in relation to the treatment of obesity as well as a variety of diseases or conditions associated with obesity. |